Clinician answer
Three paths: (1) appeal with documentation of BMI ≥30 (or ≥27 + comorbidity) and a prior lifestyle-intervention attempt — about 40% of denials reverse on appeal; (2) use the Novo WegovyCare savings card to drop cost to $499/mo; (3) switch to compounded semaglutide via a telehealth provider, $99-249/mo. Our /tools/insurance-coverage-checker shows what your plan typically covers.
Answered by Dr. Jane Novak, MD, MPH